[3] This is a known effect and not cause for concern
The escalated groups where participants started at lower doses and titrated up over weeks consistently reported fewer GI events than the single-dose groups
Important safety considerations: Patients should contact their GP if they experience severe injection site reactions, signs of infection (fever, spreading erythema), chest pain, palpitations, or allergic symptoms
Sayyah M, Olapour A, Saeedabad YS, Parast RY, Malayeri A
Comparative effectiveness of GLP1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
exendin-4